Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Return on Assets (2016 - 2025)

Historic Return on Assets for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to 0.41%.

  • Altimmune's Return on Assets rose 2300.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.54% for FY2024, which is 1200.0% down from last year.
  • According to the latest figures from Q3 2025, Altimmune's Return on Assets is 0.41%, which was up 2300.0% from 0.51% recorded in Q2 2025.
  • Altimmune's 5-year Return on Assets high stood at 0.24% for Q1 2021, and its period low was 0.66% during Q4 2024.
  • Over the past 5 years, Altimmune's median Return on Assets value was 0.45% (recorded in 2023), while the average stood at 0.46%.
  • In the last 5 years, Altimmune's Return on Assets crashed by -2400bps in 2022 and then soared by 2300bps in 2025.
  • Altimmune's Return on Assets (Quarter) stood at 0.43% in 2021, then grew by 8bps to 0.39% in 2022, then decreased by -20bps to 0.47% in 2023, then tumbled by -41bps to 0.66% in 2024, then surged by 38bps to 0.41% in 2025.
  • Its Return on Assets was 0.41% in Q3 2025, compared to 0.51% in Q2 2025 and 0.61% in Q1 2025.